Is ABT a good dividend stock?

Written by Admin | Last Updated: July 2026

Abbott Laboratories (ABT) is widely regarded by income investors and financial advisors as an exceptional dividend stock, boasting elite status as a member of the Dividend Kings. The corporation has successfully increased its consecutive annual dividend payouts for over half a century, backed by a century-long history of uninterrupted quarterly distributions. This remarkable track record highlights the firm's robust cash flow generation, resilient business model spanning medical devices, diagnostics, and nutrition, and disciplined capital allocation strategies. Even through major macroeconomic recessions and corporate restructurings, management has consistently prioritized rewarding shareholders, making it a cornerstone holding for long-term income portfolios.

Related FAQs

Yes, Acadia Healthcare Co. Inc. reached a settlement agreement in a class action securities lawsuit. The company and various individual defendants agreed to pay a total of $179 million to settle allegations that they provided materially false or m...

Landing a job at Albertsons Companies—one of the largest supermarket and food retail chains in the United States—is generally straightforward for frontline retail store operations, though corporate roles are more selective. Entry-level store posit...

C.S. Venkatakrishnan, serving as the Group Chief Executive Officer of Barclays PLC, commands an elite executive remuneration package reflecting leadership in global investment and retail banking. His total annual compensation package reaches appro...

Abbott Laboratories maintains a high level of operational profitability, supported by its globally diversified business model across medical devices, diagnostics, nutritional products, and established pharmaceuticals. The company consistently gene...